Nathaniel Calloway
CIK 1952771 · last filed 2025-04-07
Nathaniel Calloway is a corporate insider who has filed 9 SEC Form 4 insider transactions across 2 companies since 2022. The most recent filing, for ANEB, was dated Apr 7, 2025. Current disclosed insider exposure totals $327.5K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$327.5K
2
9
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Anebulo Pharmaceuticals, Inc. (ANEB) Delisted | Director | — | $0.36 | — | $0 | 3 | 2025-04-07 |
| LFCR | Director | 58,069 | $5.64 | $327.5K | $0 | 6 | 2024-07-10 |
Recent Filings
9 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-04-07 | Anebulo Pharmaceuticals, Inc. (ANEB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-07-10 | LFCR | Grant (A) | +30,000 | $0 | EDGAR |
| 2024-06-17 | Anebulo Pharmaceuticals, Inc. (ANEB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-02-02 | LFCR | Exer (M) | +3,981 | $0 | EDGAR |
| 2024-01-10 | LFCR | Exer (M) | +5,906 | $0 | EDGAR |
| 2023-06-05 | LFCR | Grant (A) | +18,182 | $0 | EDGAR |
| 2023-02-02 | LFCR | Grant (A) | — | $0 | EDGAR |
| 2023-01-11 | LFCR | Grant (A) | — | $0 | EDGAR |
| 2022-11-02 | Anebulo Pharmaceuticals, Inc. (ANEB) Delisted | Grant (A) | — | $0 | EDGAR |